Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.

17 entriesShowing 13–17

Veterinary nutrition consultation with a dog and caregiver

Named profile Stangest OncoVet I: Product ProfileRepresentative category illustration – no product packaging is shown.

Herbal Formula · Nutrition Support · Supplement · Stangest OncoVet · Dogs & Cats · After Surgery · During Chemotherapy

Stangest OncoVet I: Product Profile

Stangest OncoVet I is a named branded product for Dogs and cats as described in the manufacturer oncology materials; manufacturer positioning must be kept separate from independent clinical…

Named profile Stangest OncoVet II: Product ProfileRepresentative category illustration – no product packaging is shown.

Nutrition Support · Supplement · Stangest OncoVet · Dogs & Cats · After Surgery · During Chemotherapy · During Radiation

Stangest OncoVet II: Product Profile

Stangest OncoVet II is a named branded product for Dogs and cats; manufacturer positioning must be kept separate from independent clinical evidence.

Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiver

Named profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.

Immunotherapy · Prescription Drug · Gilvetmab · Dogs · During Targeted Therapy · New Diagnosis · Published Study

Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile

gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Named profile Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label ProfileRepresentative category illustration – no product packaging is shown.

Immunotherapy · Prescription Drug · Oncept IL-2 · Cats · After Surgery · During Radiation · Published Study

Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label Profile

feline interleukin-2 recombinant canarypox virus (vCP1338) is covered as veterinary biologic immunotherapy used with surgery and radiotherapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a…

Caregiver and veterinary professional reviewing symptom observations for a dog

Named profile H1 and H2 Blockade Around Mast-Cell Degranulation RiskRepresentative category illustration – no product packaging is shown.

Prescription Drug · Supportive-care medicine · Mast-cell mediator blockade · Dogs · During Targeted Therapy · Veterinary Clinical Use · Label-linked companion-medication context

H1 and H2 Blockade Around Mast-Cell Degranulation Risk

H1-receptor and H2-receptor blocking companion medicines is covered as protocol-linked supportive medicines; not direct antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led…